Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $11.48 in the prior trading day, BrightSpring Health Services Inc (NASDAQ: BTSG) closed at $11.37, down -0.96%. In other words, the price has decreased by -$0.96 from its previous closing price. On the day, 0.73 million shares were traded. BTSG stock price reached its highest trading level at $11.515 during the session, while it also had its lowest trading level at $11.28.
Ratios:
Our goal is to gain a better understanding of BTSG by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 1.26. In the meantime, Its Debt-to-Equity ratio is 1.84 whereas as Long-Term Debt/Eq ratio is at 1.75.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, HSBC Securities on March 06, 2024, initiated with a Buy rating and assigned the stock a target price of $13.
On February 27, 2024, Deutsche Bank Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $11.50.
On February 20, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $15.Wells Fargo initiated its Overweight rating on February 20, 2024, with a $15 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 15 ’24 when ROUSSEAU JON B bought 18,400 shares for $8.09 per share. The transaction valued at 148,856 led to the insider holds 369,763 shares of the business.
ROUSSEAU JON B bought 18,400 shares of BTSG for $148,856 on Mar 15 ’24. The insider now owns 1,025,636 shares after completing the transaction at $8.09 per share. On Mar 15 ’24, another insider, Mattingly James F Jr, who serves as the insider of the company, bought 6,080 shares for $8.26 each. As a result, the insider paid 50,221 and bolstered with 134,780 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTSG now has a Market Capitalization of 1947908352 and an Enterprise Value of 4800745472. Its current Enterprise Value per Revenue stands at 0.512 whereas that against EBITDA is 15.792.
Stock Price History:
Over the past 52 weeks, BTSG has reached a high of $12.14, while it has fallen to a 52-week low of $7.85. The 50-Day Moving Average of the stock is 13.59%, while the 200-Day Moving Average is calculated to be 11.04%.
Shares Statistics:
The stock has traded on average 1.86M shares per day over the past 3-months and 1001090 shares per day over the last 10 days, according to various share statistics. A total of 171.19M shares are outstanding, with a floating share count of 52.83M. Insiders hold about 69.16% of the company’s shares, while institutions hold 2.19% stake in the company. Shares short for BTSG as of 1713139200 were 14644830 with a Short Ratio of 7.88, compared to 1710460800 on 11510618. Therefore, it implies a Short% of Shares Outstanding of 14644830 and a Short% of Float of 28.27.
Earnings Estimates
The current market rating for BrightSpring Health Services Inc (BTSG) reflects the collective analysis of 9 analysts closely monitoring its performance.On average, analysts expect EPS of $0.17 for the current quarter, with a high estimate of $0.35 and a low estimate of $0.1, while EPS last year was $0.14. The consensus estimate for the next quarter is $0.16, with high estimates of $0.34 and low estimates of $0.1.
Analysts are recommending an EPS of between $1.25 and $0.48 for the fiscal current year, implying an average EPS of $0.64. EPS for the following year is $0.85, with 10.0 analysts recommending between $1.8 and $0.36.
Revenue Estimates
For the next quarter, 9 analysts are estimating revenue of $2.55B. There is a high estimate of $2.7B for the next quarter, whereas the lowest estimate is $2.35B.
A total of 11 analysts have provided revenue estimates for BTSG’s current fiscal year. The highest revenue estimate was $10.78B, while the lowest revenue estimate was $9.42B, resulting in an average revenue estimate of $10.18B. In the same quarter a year ago, actual revenue was $8.83BBased on 11 analysts’ estimates, the company’s revenue will be $11.08B in the next fiscal year. The high estimate is $11.99B and the low estimate is $10.13B.
